How to Get Armour Thyroid in Maryland

What Armour Thyroid Actually Is and Why Maryland Patients Request It

Armour Thyroid is a prescription natural desiccated thyroid (NDT) tablet that contains both thyroxine (T4) and triiodothyronine (T3) extracted from porcine thyroid glands. Each grain (60 mg) delivers approximately 38 mcg T4 and 9 mcg T3, giving it a T4:T3 ratio of roughly 4.2:1. That ratio differs from the human thyroid's natural output, which is closer to 14:1. Still, many patients report symptom relief on NDT that they did not achieve on levothyroxine monotherapy.

The evidence base for that preference is not trivial. Hoang et al. (J Clin Endocrinol Metab, 2013, N=70) found that 48.6% of hypothyroid patients preferred desiccated thyroid extract over levothyroxine after a blinded crossover trial, and the NDT group lost a mean of 4 lbs more than the levothyroxine group over 16 weeks [1]. The American Thyroid Association's 2014 guidelines acknowledge that "combination T4/T3 therapy may benefit a subset of patients" while noting the evidence base is still maturing [2]. Maryland physicians are free to prescribe NDT when clinical judgment supports it, and no Maryland statute restricts NDT prescribing beyond standard Schedule V / prescription-only requirements.

Armour Thyroid is FDA-approved and manufactured by Allergan under a New Drug Application dating to the pre-1938 grandfathered drug framework, which means it appears on FDA labeling databases but was not subject to modern randomized controlled trial approval [3]. That regulatory history matters to insurance reviewers, as discussed in the prior authorization section below.

Maryland Prescribers Who Can Write an Armour Thyroid Prescription

Any Maryland-licensed MD, DO, nurse practitioner (NP) with full prescriptive authority, or physician assistant (PA) operating under a supervising physician agreement can legally prescribe Armour Thyroid. Maryland is a full-practice authority state for NPs under the Maryland Nurse Practice Act, meaning NPs do not require physician co-signature after completing a 2-year collaborative practice period [4]. PAs in Maryland require a delegation agreement but can prescribe Schedule II through V drugs within that agreement.

Specialists who routinely prescribe NDT include endocrinologists, integrative medicine physicians, and functional medicine-trained providers. Primary care physicians (family medicine and internal medicine) also write NDT prescriptions regularly. The practical difference is wait time. A new-patient appointment with a Maryland endocrinologist at academic medical centers such as Johns Hopkins or University of Maryland Medical System often runs 6 to 12 weeks out. A telehealth visit through a hormone-focused practice typically runs 24 to 72 hours.

Patients should verify that any telehealth provider holds an active Maryland medical license before booking. The Maryland Board of Physicians license lookup is publicly available at boards.maryland.gov. Prescribing a controlled substance or prescription-only drug via telehealth to a Maryland patient without a valid Maryland license is a violation of both state and federal law under the Ryan Haight Online Pharmacy Consumer Protection Act [5].

Required Labs Before an Armour Thyroid Prescription Is Issued

A Maryland clinician will not prescribe Armour Thyroid without at least one recent thyroid lab value in the chart. The minimum acceptable panel at most practices includes TSH and Free T4. A clinically complete workup adds Free T3, reverse T3, thyroid peroxidase antibodies (TPO-Ab), and thyroglobulin antibodies (TgAb) to characterize the underlying etiology.

Specific reference ranges to know before your visit:

• TSH: 0.45 to 4.50 mIU/L (most laboratory normal ranges); many NDT-prescribing clinicians target 1.0 to 2.5 mIU/L on therapy
• Free T4: 0.8 to 1.8 ng/dL
• Free T3: 2.3 to 4.2 pg/mL
• TPO-Ab: <35 IU/mL (positive result suggests Hashimoto's thyroiditis as the underlying cause)

A TSH above 4.50 mIU/L on two separate draws at least 6 weeks apart meets the diagnostic threshold for hypothyroidism under ATA guidelines [2]. Subclinical hypothyroidism (TSH 4.5 to 10 mIU/L with normal Free T4) may also be treated at clinician discretion, particularly when TPO antibodies are elevated, per a 2019 European Thyroid Journal consensus statement [6].

Labs can be ordered through your telehealth provider before the visit, drawn at any LabCorp or Quest Diagnostics location in Maryland, or pulled from existing records if dated within the past 6 months. Most telehealth platforms accept PDF uploads of prior lab results. Some require results within 90 days for dose-adjustment visits.

Follow-up labs after starting Armour Thyroid are standard at 6 to 8 weeks post-initiation, then every 6 months once the dose is stable. The American Association of Clinical Endocrinology (AACE) recommends checking TSH 4 to 8 weeks after any dose change [7].

How Telehealth Prescribing Works for Armour Thyroid in Maryland

Maryland formally permits telehealth prescribing under the Maryland Telehealth Advancement Act and subsequent Board of Physicians guidance. A prescriber-patient relationship can be established through synchronous audio-video visits without an in-person examination for most non-controlled medications, including Armour Thyroid [8].

The typical Maryland telehealth workflow for Armour Thyroid looks like this:

1. Patient completes online intake form with symptom history, current medications, and prior thyroid diagnoses.
2. Lab results are uploaded or ordered through the platform's partner lab network.
3. A 20-to-40-minute synchronous video consult is conducted with a licensed Maryland prescriber.
4. If NDT is clinically appropriate, a prescription is sent electronically to the patient's chosen pharmacy, usually within 24 hours of the visit.
5. A follow-up visit at 6 to 8 weeks reviews repeat labs and adjusts dose if needed.

Platforms that operate nationally and hold Maryland provider licenses include HealthRX and several other hormone-focused telehealth practices. Before enrolling, confirm that the specific physician or NP assigned to your case carries a Maryland license, not just the platform's business registration. Ask directly: "Does the clinician who will see me hold an active Maryland Board of Physicians license?"

Telehealth visits for thyroid management are reimbursable under Maryland Medicaid and most commercial plans following the COVID-era telehealth expansions that Maryland has made permanent for behavioral and medical services [9].

Armour Thyroid Pharmacies in Maryland: Retail, Mail-Order, and 503A Compounding

Retail and Mail-Order Pharmacies

Armour Thyroid manufactured by Allergan is a commercially available tablet stocked by most major retail chains in Maryland, including CVS, Walgreens, Giant Food Pharmacy, and Rite Aid. Independently owned pharmacies often stock it as well. If a specific strength is temporarily out of stock (a recurring issue that affected supply between 2020 and 2022), ask the pharmacist to check the 30 mg, 60 mg, and 90 mg strengths separately, as supply problems have historically been strength-specific.

Mail-order pharmacies such as CVS Caremark, Express Scripts, and Optum Rx can fill a 90-day supply. GoodRx and similar discount programs reduce cash-pay cost significantly. As of mid-2025, a 90-tablet supply of Armour Thyroid 60 mg retails for approximately $45 to $75 cash-pay at Maryland pharmacies with a GoodRx coupon.

503A Compounding Pharmacies in Maryland

Maryland-licensed 503A compounding pharmacies can compound natural desiccated thyroid (NDT) preparations for patients with documented clinical need, such as dye sensitivity to commercial tablet fillers or a requirement for a non-standard dose that commercial tablets cannot achieve [10]. The FDA's guidance on compounding distinguishes 503A (patient-specific, licensed pharmacy) from 503B (outsourcing facility for bulk production), and NDT compounding under 503A remains legal in Maryland provided it is not commercially available in the specific form prescribed [11].

Common reasons a Maryland clinician may write for compounded NDT instead of commercial Armour Thyroid include:

• Gluten sensitivity (commercial Armour Thyroid contains dextrose and no gluten, but some patients still react to excipients)
• Need for a dose not achievable by splitting commercial tablets (e.g., 45 mg or 75 mg)
• Documented allergy to tablet coating materials

Compounded NDT from a 503A pharmacy is not bioequivalent-rated against Allergan's Armour Thyroid, meaning your prescriber should specify whether you are switching between the two formulations and plan a re-check lab at 6 weeks [12].

Prior Authorization for Armour Thyroid Under Maryland Insurance Plans

Maryland Medicaid covers Armour Thyroid for hypothyroidism with prior authorization (PA). Commercial insurers in Maryland vary widely. Some cover NDT at formulary tier 2 or 3 without PA; others require step therapy through levothyroxine first.

A prior authorization request for Armour Thyroid in Maryland typically requires the following documentation:

• Confirmed hypothyroidism diagnosis (ICD-10 code E03.9 or E06.3 for Hashimoto's) with lab evidence
• Current TSH and Free T4 values
• Documentation of a trial of levothyroxine (typically 90 days) with inadequate symptom response or intolerance, or a clinical rationale for why levothyroxine is contraindicated
• Letter of medical necessity from the prescribing clinician
• NDC code for Armour Thyroid (71800-0011-XX series for Allergan tablets)

The ATA and AACE jointly published a 2012 position statement affirming that NDT "should not be used routinely" but acknowledging "it may be appropriate in individual patients" [13]. Insurers often use this language to require a levothyroxine trial first. Your prescriber can counter-argue with Hoang et al. (2013) data showing statistically superior patient preference and weight outcomes for NDT in that 70-patient crossover trial [1].

If a PA is denied, Maryland law gives you the right to an internal appeal within 30 days and an external review through the Maryland Insurance Administration if the internal appeal fails [14]. The external review decision is binding on the insurer.

Dosing and Titration Protocol for Armour Thyroid

Armour Thyroid is dosed once daily on an empty stomach, at least 30 to 60 minutes before food, coffee, or other medications. Common interacting substances to separate include calcium supplements, iron supplements, antacids containing aluminum or magnesium, and proton pump inhibitors, all of which reduce T4 and T3 absorption [15].

Standard starting dose is 30 mg (0.5 grain) in thyroid-naive patients or those converting from low-dose levothyroxine. Titration proceeds in 15 to 30 mg increments every 4 to 6 weeks guided by repeat TSH and Free T3. Most adults stabilize between 60 mg and 120 mg per day (1 to 2 grains), though some patients with severe hypothyroidism or post-thyroidectomy require up to 180 mg or more.

Levothyroxine-to-NDT conversion approximation: 100 mcg levothyroxine is roughly equivalent to 60 mg (1 grain) of Armour Thyroid. This conversion is a starting estimate, not a precise equivalence, because the T3 content of NDT is absorbed faster and acts more acutely than T4 [16]. Over-replacement with NDT can suppress TSH below 0.1 mIU/L, which is associated with atrial fibrillation risk and reduced bone mineral density in postmenopausal women per a large cohort analysis published in JAMA Internal Medicine (N=4,291) [17].

Symptoms of appropriate dose: normalized energy levels, resolution of cold intolerance, stable weight, resting heart rate 60 to 80 bpm, and a TSH in the patient's individual target range.

Transferring an Existing Armour Thyroid Prescription to Maryland

If you hold a valid Armour Thyroid prescription from a provider in another state and relocate to Maryland, you have several options. A retail pharmacy in Maryland can accept a transfer from an out-of-state pharmacy for a non-controlled prescription drug. Call the Maryland pharmacy with your current pharmacy's name and phone number; the receiving pharmacist will coordinate the transfer directly.

Mail-order pharmacies with national networks (CVS Caremark, Express Scripts) automatically allow prescription fills at Maryland addresses for plans enrolled through those networks.

Your out-of-state prescription remains valid at a Maryland pharmacy for the duration of its authorized refills, provided the original prescribing physician held a valid license in the state where they issued the prescription. Maryland does not require the prescriber to hold a Maryland license to honor an out-of-state prescription at a Maryland pharmacy. However, if you need a new prescription or a dose adjustment, you will need a Maryland-licensed prescriber [5].

Practically, most patients relocating to Maryland book a telehealth follow-up visit with a Maryland-licensed provider within 30 days to establish care and ensure continuity of their NDT prescription without a gap in therapy.

What to Expect in the First 30 Days on Armour Thyroid

Week one on a new Armour Thyroid prescription may bring a transient increase in heart rate, mild palpitations, or increased warmth. These effects reflect the rapid absorption of T3, which peaks in serum within 2 to 4 hours of ingestion, compared to T4 which peaks at 2 to 4 hours but requires peripheral conversion before exerting full effect [16].

Most patients do not notice meaningful symptom improvement in week one. Clinical response to T4 normalization typically takes 4 to 6 weeks because cellular thyroid hormone receptors require time to reset their expression. Patients who expect overnight improvement are likely to report dissatisfaction that does not reflect the drug's actual efficacy.

A 2020 systematic review in Frontiers in Endocrinology covering 23 studies on hypothyroid treatment outcomes noted that quality-of-life measures on combination T4/T3 therapy, including NDT, improved significantly relative to T4 monotherapy in 10 of the 23 included studies [18]. The studies with the strongest methodology used validated tools such as the ThyPRO-39 questionnaire, which measures thyroid-specific quality of life across 13 domains.

Patients starting NDT after years on levothyroxine may experience a transient TSH suppression at equivalent doses because the T3 component suppresses pituitary TSH output more aggressively than T4 alone. This is an expected pharmacological effect, not a sign of over-treatment, but it should be interpreted in clinical context rather than in isolation.